Department of Biotechnology, Bhupat & Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India ...

Catani and colleagues provide data on antigenic properties of neuraminidase proteins of pandemic H1N1 and show that antigenic diversity of the neuraminidase from 2009 to 2020 largely falls into two ...

Owing to its novel mechanism of action, tenapanor can be used in combination with phosphate binders to further significantly reduce serum phosphate levels and improve the rate of achieving target ...

who have an inadequate response or are intolerant to phosphorus binders. As the world's first and currently only approved phosphate absorption inhibitor, Tenapanor Hydrochloride Tablets has been ...

Starting Jan. 1, Medicare rolled payments for seven different oral-only phosphate binders into its End Stage Renal Disease Prospective Payment System, a bundle in place since 2011. Most affected ...

who have an inadequate response or are intolerant to phosphorus binders. As the world's first and currently only approved phosphate absorption inhibitor, Tenapanor Hydrochloride Tablets has been ...

The transition of oral phosphate binders to the SEDAPA program could add up to $50 million in profitability. Potential expiration of ACA subsidies may pose a $75 million to $120 million headwind.

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Serum phosphorus concentrations are seldom less than 2.0 mg/dl (0.6 mmol/1) unless patients' phosphorus intake is low or they simultaneously ingest phosphate-binding antacids. [34] Severe ...